CureGenetics Funding: $96M Raised, Series B (2024)
CureGenetics is based in San Diego. It has raised $96M in total funding. Latest round: Series B.
CureGenetics funding overview
CureGenetics is based in San Diego. CureGenetics has raised $96M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in March 2024. The round record for CureGenetics runs through 2024; nothing later has been disclosed. Investors on record include Formic Ventures, Qiming Venture Partners, Bill Gates, Scott Becker, Ascendin Investment, CTS Capital. 6 distinct backers are named across the disclosed rounds.
CureGenetics at a glance
Total raised
$96M
Latest round
Series B
Latest round date
March 2024
Headquarters
San Diego
Notable investors
Formic Ventures, Qiming Venture Partners, Bill Gates, Scott Becker, Ascendin Investment, CTS Capital
Frequently asked about CureGenetics funding
How much has CureGenetics raised?
CureGenetics has raised $96M in total disclosed funding across the rounds on record.
Who has invested in CureGenetics?
Formic Ventures, Qiming Venture Partners, Bill Gates, Scott Becker, Ascendin Investment, CTS Capital are named among the investors backing CureGenetics.
What was the latest CureGenetics funding round?
The most recent disclosed round is a Series B, announced in March 2024.
Where is CureGenetics based?
CureGenetics is based in San Diego.
When did CureGenetics last raise?
The last disclosed CureGenetics round closed in March 2024 at Series B.
CureGenetics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.
